The 14-3-3σ gene promoter is methylated in both human melanocytes and melanoma

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Liu, Suhu ^a   Howell, Paul ^b   Ren, Suping ^b   Fodstad, Oystein ^c,d   Riker, Adam I ^e  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e Ochsner Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STRATIFIN; TRICHOSTATIN A; PROTEIN 14 3 3;

AMINO ACID SEQUENCE; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; DEMETHYLATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL CULTURE; CPG ISLAND; DNA METHYLATION; GENETICS; METABOLISM; TUMOR CELL LINE;

14-3-3 PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; CPG ISLANDS; DNA METHYLATION; HUMANS; MELANOCYTES; MELANOMA; PROMOTER REGIONS, GENETIC;

EID: 67649798229     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-162     Document Type: Article

References (20)

1. Mhawech P 14-3-3 proteins - an update Cell Res 2005, 15:228-236 10.1038/ sj.cr.7290291 15857577
2. Hermeking H Lengauer C Polyak K He TC Zhang L Thiagalingam S Kinzler KW Vogelstein B 14-3-3sigma is a p53-regulated inhibitor of G2/M progression Mol Cell Biol 1997, 1:3-11
3. Umbricht C Evron E Gabrielson E Ferguson A Marks J Sukumar S Hypermethylation of 14-3-3sigma (stratifin) is an early event in breast cancer Oncogene 2001, 20:3348-3353 10.1038/sj.onc.1204438 11423985
4. Iwata N Yamamoto H Sasaki S Itoh F Suzuki H Kikuchi T Kaneto H Iku S Ozeki I Karino Y Satoh T Toyota J Satoh M Endo T Imai K Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma Oncogene 2000, 19:5298-5302 10.1038/sj.onc.1203898 11077447
5. Gasco M Sullivan A Repellin C Brooks L Farrell PJ Tidy JA Dunne B Gusterson B Evans DJ Crook T Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia Oncogene 2002, 21:1876-1881 10.1038/sj.onc.1205256 11896620
6. Kang G Lee S Kim WH Lee HW Kim JC Rhyu MG Ro JY Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma Am J Pathol 2002, 160:787-794 1867170 11891177
7. Gasco M Bell AK Heath V Sullivan A Smith P Hiller L Yulug I Numico G Merlano M Farrell PJ Tavassoli M Gusterson B Crook T Epigenetic inactivation of 14-3-3sigma in oral carcinoma: Association with p16(INK4a) silencing and human papillomavirus negativity Cancer Res 2002, 62:2072-2076 11929827
8. Akahira J Sugihashi Y Suzuki T Ito K Niikura H Moriya T Nitta M Okamura H Inoue S Sasano H Okamura K Yaegashi N Decreased expression of 14-3-3sigma is associated with advanced disease in human epithelial ovarian cancer: Its correlation with aberrant DNA methylation Clin Cancer Res 2004, 10:2687-2693 10.1158/1078-0432.CCR-03-0510 15102672
9. Mhawech P Benz A Cerato C Greloz V Assaly M Desmond JC Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation Mod Pathol 2005, 18:340-348 10.1038/ modpathol.3800240 15257317
10. Fodstad O Aamdal S McMenamin M Nesland JM Pihl A A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX Int J Cancer 1988, 41:442-449 10.1002/ijc.2910410322 3346110
11. Welch D Bisi JE Miller BE Conaway D Seftor EA Yohem KH Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line Intl J Cancer 1991, 47:227-237 10.1002/ijc.2910470211
12. Riker AI Isolation and culture of melanoma cell lines Methods Mol Med 2004, 88:93-99 14634220
13. Herman J Graff JR Myöhänen S Nelkin BD Baylin SB Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 1996, 93:9821-9826 38513 8790415 10.1073/pnas.93.18.9821
14. Chalitchagorn K Shuangshoti S Hourpai N Kongruttanachok N Tangkijvanich P Thong-ngam D Voravud N Sriuranpong V Mutirangura A Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis Oncogene 2004, 23:8841-8816 10.1038/sj.onc.1208137 15480421
15. Futscher B Oshiro MM Wozniak RJ Holtan N Hanigan CL Duan H Domann FE Role for DNA methylation in the control of cell type specific maspin expression Nat Genet 2002, 31:175-179 10.1038/ng886 12021783
16. De Smet C Lurquin C Lethé B Martelange V Boon T DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter Mol Cell Biol 1999, 19:7327-7335 84726 10523621
17. Oshiro M Futscher BW Lisberg A Wozniak RJ Klimecki WT Domann FE Epigenetic regulation of the cell type-specific gene 14-3-3sigma Neoplasia 2005, 7:799-808 1501934 16229802 10.1593/neo.05274
18. Ferguson A Evron E Umbricht CB Pandita TK Chan TA Hermeking H Marks JR Lambers AR Futreal PA Stampfer MR Sukumar S High frequency of hypermethylation at the 14-3-3sigma locus leads to gene silencing in breast cancer Proc Natl Acad Sci USA 2000, 97:6049-6054 18556 10811911 10.1073/pnas.100566997
19. Wilker E van Vugt MA Artim SA Huang PH Petersen CP Reinhardt HC 14-3-3sigma controls mitotic translation to facilitate cytokinesis Nature 2007, 446:329-332 10.1038/nature05584 17361185
20. Rae J Creighton CJ Meck JM Haddad BR Johnson MD MDA-MB-435 cells are derived from M14 melanoma cells - a loss for breast cancer, but a boon for melanoma research Breast Cancer Res Treat 2007, 104:13-19 10.1007/ s10549-006-9392-8 17004106